Pharmaceutical
Technology
Health

Cleveland BioLabs

$1.47
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-2.49%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell CBLI and other stocks, options, ETFs, and crypto commission-free!

About

Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. Read More It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY.

Employees
16
Headquarters
Buffalo, New York
Founded
2003
Market Cap
16.61M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
14.81K
High Today
$1.49
Low Today
$1.47
Open Price
$1.49
Volume
760.00
52 Week High
$3.16
52 Week Low
$1.00

Collections

Pharmaceutical
Technology
Health
Biotechnology
Biopharmaceutical
Research And Development
US
North America

Earnings

-$0.11
-$0.07
-$0.04
$0.00
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
-$0.08 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.